Publications

• The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations

  Schaper-Gerhardt, K., Gutzmer, R., Angela, Y., Zimmer, L., Livingstone, E., Schadendorf, D., Hassel, J. C., Weishaupt, C., Remes, B., Kubat, L., Spassova, I., Becker, J. C.

  PMID: 38479119 Show Details link to full text
  Study

  BONEMET

  Year

  2024

  Keywords

  • immunotherapy
  • melanoma

• Design and Rationale of MYOFLAME-19 RCT: MYOcardial protection to reduce inFLAMmatory heart disease due to COVID-19 Infection using CMR Endpoints

  V. O. Puntmann , D. Beitzke, A. Kammerlander, I. Voges, D. D. Gabbert, M. Doerr, B. Chamling, B. Bozkurt, J. C. Kaski, E. Spatz, E. Herrmann, G. Rohde, P. DeLeuw, L. Taylor, C. Windemuth-Kieselbach, C. Harz, M. Santiuste, L. Schoeckel, J. Hirayama, P. C. Taylor, C. Berry, E. Nagel

  PMID: 39481808 Show Details link to full text
  Study

  MYOFLAME-19

  Year

  2024

  Keywords

  • cardiovascular
  • COVID-19

• real-world use of teriflunomide in Germany and changes in treatment patterns over time

  B.-A. Kallmann, G. Zu Eulenburg, J.S. Kullmann, M. Mäurer

  PMID: 38808094 Show Details link to full text
  Study

  TAURUS-MS II

  Year

  2024

  Keywords

  • multiple sclerosis

• InspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices

  C. Wanner, E. Schaeffner, T. Frese, C. Weber, P. Stahl, F. Scherg, F. Burckhardt, U. Opfermann, F. Radowsky, F. Mader

  PMID: 38575833 Show Details link to full text
  Study

  InspeCKD

  Year

  2024

  Keywords

  • CKD

• DETECT IPN: Real-World Experience with Automated Detection of Incidental Pulmonary Nodules in an All-Comer Population

  Johannes Dunsche, Hans-Ulrich Kauczor, Oyunbileg V. Stackelberg, Isabelle Ayx, Rimma Kondrashova, Jens Vogel-Claussen, Joana Lamché, Gerald Schmid-Bindert

  PMID: 10.4236/ojrad.2025.151002 Show Details link to full text
  Study

  DETECT IPN

  Year

  2025

  Keywords

  • lung cancer

• Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial

  E. Livingstone; H. Gogas; L. Kandolf-Sekulovic; F. Meier; T.K. Eigentler; M. Ziemer; P.A.M. Terheyden; A.H. Gesierich; R.A. Herbst; K.C. Kähler; D.C. Ziogas; Z. Mijuskovic; M. Garzarolli; C. Garbe; A. Roesch; S. Ugurel; R. Gutzmer; J.J. Grob; F. Kiecker; J. Utikal; C. Windemuth-Kieselbach; S. Eckhardt; L. Zimmer; D. Schadendorf

  PMID: 10.1016/j.ejca.2023.112941 Show Details link to full text
  Study

  ImmunoCobiVem

  Year

  2023

  Keywords

  • melanoma

• Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

  Prof Jürgen C Becker, MD PhD; Prof Selma Ugurel, MD; Prof Ulrike Leiter, MD; Prof Friedegund Meier, MD; Prof Ralf Gutzmer, MD; Prof Sebastian Haferkamp, MD; Lisa Zimmer, MD; Elisabeth Livingstone, MD; Prof Thomas K Eigentler, MD; Prof Axel Hauschild, MD: Felix Kiecker, MD; Prof Jessica C Hassel, MD; Peter Mohr, MD; Michael Fluck, MD; Ioannis Thomas, MD; Marlene Garzarolli, MD; Imke Grimmelmann, MD; Konstantin Drexler, MD; Alexandra N Spillner, PhD; Sebastian Eckhardt, MS; Prof Dirk Schadendorf, MD

  PMID: Show Details link to full text
  Study

  ADMEC-O

  Year

  2023

  Keywords

  • immunotherapy
  • nivolumab
  • Merkel cell carcinoma

• Design and Rationale of MYOFLAME-19 RCT: MYOcardial protection to reduce inFLAMmatory heart disease due to COVID-19 Infection using CMR Endpoints

  Valentina O Puntmann, Dietrich Beitzke, Andreas Kammerlander, Inga Voges, Dominik D Gabbert, Marcus Doerr, Bishwas Chamling, Biykem Bozkurt, Juan Carlos Kaski, Erica Spatz, Eva Herrmann, Gernot Rohde0, Philipp DeLeuw, Lenka Taylor, Christine Windemuth-Kieselbach, Cornelia Harz, Marta Santiuste, Laura Schoeckel, Juliana Hirayama, Peter C Taylor, Colin Berry, Eike Nagel

  PMID: 39481808 Show Details link to full text
  Study

  MYOFLAME-19

  Year

  2024

  Keywords

  • cardiovascular
  • COVID-19

• TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time

  Boris-Alexander Kallmann, Georg zu Eulenburg, Jennifer S. Kullmann, Mathias Mäurer

  PMID: 10.1177/17562864241252722 Show Details link to full text
  Study

  TAURUS-MS II

  Year

  2024

  Keywords

• InspeCKD - Analysis of the use of diagnostics in patients at high risk for chronic kidney disease in German general practitioner (GP) practices

  Christoph Wanner, Elke Schaeffner, Thomas Frese, Christoph Weber, Philipp Stahl, Felix Scherg, Fabian Burckhardt, Ulrich Opfermann, Frank Radowsky, Frederik Mader

  PMID: 10.1007/s15006-024-3684-y Show Details link to full text
  Study

  inspeCKD

  Year

  2024

  Keywords

  • CKD